BridgeMD
New treatment option for Juvenile Idiopathic Arthritis (JIA)
Official title Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis
ClinicalTrials.gov ID: NCT07234747
What this study is testing
- What it's testing
- Juvenile Idiopathic Arthritis (JIA) is the most common inflammatory, autoimmune, and chronic rheumatic disease of childhood (1). In individuals diagnosed with JIA, increased inflammation leads to joint swelling, tenderness, restricted range of motion, and pain (2,3).
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 12
You may be able to join if
- Being between the ages of 8 and 13
- Having been diagnosed with JIA at least 6 months prior
- Willingness to participate in the study
You likely can't join if
- Having a balance problem due to vestibular or neurological conditions
- Having undergone surgery in the last 6 months that may interfere with exercise participation
- Inability to comply with the exercise program
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Buyukcekmece, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Buyukcekmece, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.